Altimmune to report first quarter 2024 financial results and provide business update on may 9, 2024

Gaithersburg, md., may 02, 2024 (globe newswire) -- altimmune, inc. (nasdaq: alt), a clinical-stage biopharmaceutical company, today announced that it will report its first quarter 2024 financial results on thursday, may 9, 2024 and will provide a business update.
ALT Ratings Summary
ALT Quant Ranking